Clinical Trial Update: IAMA-6 Oral Dose Study in Healthy Adults [Phase 1]

View source ↗

Summary

This update confirms completion of a Phase 1 oral dose study (IAMA-6) in healthy adults investigating therapy for neurodevelopmental disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurodevelopmental Disorders

Drugs mentioned

• IAMA-6

Snippet

Sponsor: Iama Therapeutics S.r.l. | Conditions: Neurodevelopmental Disorders | Phase 1 | Status: COMPLETED